Summary
Thermo Fisher Scientific Inc. (TMO) filed an 8-K on October 21, 2015, to report its financial results for the fiscal quarter ended September 26, 2015. The key information released was contained within a press release furnished as an exhibit to the filing. While the 8-K itself does not provide specific financial figures, it serves as the official notification of the release of these results, which are crucial for investors to assess the company's ongoing performance and financial health. Investors should refer to the press release (Exhibit 99.1) for detailed financial data, including revenue, earnings per share, and any forward-looking guidance. This filing is important for understanding TMO's recent operational success and its trajectory within the life sciences and diagnostics market. The company's ability to meet or exceed its financial targets, as detailed in the press release, will be a primary driver of investor sentiment and valuation.
Key Highlights
- 1Thermo Fisher Scientific announced its financial results for the fiscal quarter ended September 26, 2015.
- 2The results were disclosed via a press release furnished as Exhibit 99.1 to the 8-K filing.
- 3The 8-K filing serves as official notification of the earnings release.
- 4Investors are directed to the press release for specific financial figures and operational details.
- 5The filing includes standard legal disclaimers regarding the information's treatment under SEC rules (not considered 'filed').